Ozempic shorts challenge ASX blue-chips
Ozempic, the miracle drug initially designed to combat diabetes but now renowned for its effectiveness as a weight-loss treatment, is sending shockwaves through the ASX as short sellers bet heavily against its potential impact on market valuations.
Read More